Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBP.L Regulatory News (CBP)

  • There is currently no data for CBP

Director/PDMR Shareholding

17 Jan 2023 11:23

RNS Number : 9948M
Curtis Banks Group PLC
17 January 2023
 

17 January 2023

Curtis Banks Group plc

("Curtis Banks", the "Company")

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs")

Curtis Banks, one of the UK's leading SIPP providers, hereby provides notification that on 16 January 2023 it granted certain employees, including PDMRs, share options under the Curtis Banks Group plc Long Term Incentive Plan 2017 ("LTIP"). The intention to grant such options was referred to in paragraph 11 of the Rule 2.7 announcement issued on 6 January 2023 and paragraph 3.1 of Schedule 2 to the co-operation agreement between the Company, Nucleus Clyde Acquisition Limited and Nucleus Financial Platforms Limited. Subject to the rules of the LTIP, the vesting of the options will be subject to the satisfaction of a performance condition measured over the performance period 1 January 2022 to 31 December 2024.

The notification below, made in accordance with the requirements of Article 19(3) of the UK Market Abuse Regulation, provides further detail.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Dan Cowland

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer

a)

 

Name

 

 

Curtis Banks Group Plc

b)

 

LEI

 

 

213800LYP7YTVDXRMP40

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Curtis Banks Group Plc Ordinary Shares 0.5p

Identification code

GB00BW0D4R71

b)

 

Nature of the transaction

 

 

Granted options over 37,132 ordinary shares in the Company

c)

 

Price(s) and volume(s)

Exercise Price(s)

Volume(s)

252.5p

37,132

 

 

d)

 

Aggregated information

- Aggregated volume

- Price

n/a

e)

 

Date of the transaction

 

 

16 January 2023

 

f)

Place of transaction

Outside a trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

James Keely

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Risk Officer

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer

a)

 

Name

 

 

Curtis Banks Group Plc

b)

 

LEI

 

 

213800LYP7YTVDXRMP40

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Curtis Banks Group Plc Ordinary Shares 0.5p

Identification code

GB00BW0D4R71

b)

 

Nature of the transaction

 

 

Granted options over 13,937 ordinary shares in the Company

c)

 

Price(s) and volume(s)

Exercise Price(s)

Volume(s)

252.5p

13,937

 

 

d)

 

Aggregated information

- Aggregated volume

- Price

n/a

e)

 

Date of the transaction

 

 

16 January 2023

 

f)

Place of transaction

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Gemma Millard

2

 

Reason for the notification

 

a)

 

Position/status

 

 

General Counsel

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer

a)

 

Name

 

 

Curtis Banks Group Plc

b)

 

LEI

 

 

213800LYP7YTVDXRMP40

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Curtis Banks Group Plc Ordinary Shares 0.5p

Identification code

GB00BW0D4R71

b)

 

Nature of the transaction

 

 

Granted options over 8,887 ordinary shares in the Company

c)

 

Price(s) and volume(s)

Exercise Price(s)

Volume(s)

252.5p

8,887

 

 

d)

 

Aggregated information

- Aggregated volume

- Price

n/a

e)

 

Date of the transaction

 

 

16 January 2023

 

f)

Place of transaction

Outside a trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Ihab El Saie

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer - Dunstan Thomas

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer

a)

 

Name

 

 

Curtis Banks Group Plc

b)

 

LEI

 

 

213800LYP7YTVDXRMP40

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Curtis Banks Group Plc Ordinary Shares 0.5p

Identification code

GB00BW0D4R71

b)

 

Nature of the transaction

 

 

Granted options over 11,626 ordinary shares in the Company

c)

 

Price(s) and volume(s)

Exercise Price(s)

Volume(s)

252.5p

11,626

 

 

d)

 

Aggregated information

- Aggregated volume

- Price

n/a

e)

 

Date of the transaction

 

 

16 January 2023

 

f)

Place of transaction

Outside a trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Jaynie Vincent

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Group People Officer

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer

a)

 

Name

 

 

Curtis Banks Group Plc

b)

 

LEI

 

 

213800LYP7YTVDXRMP40

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Curtis Banks Group Plc Ordinary Shares 0.5p

Identification code

GB00BW0D4R71

b)

 

Nature of the transaction

 

 

Granted options over 17,572 ordinary shares in the Company

c)

 

Price(s) and volume(s)

Exercise Price(s)

Volume(s)

252.5p

17,572

 

 

d)

 

Aggregated information

- Aggregated volume

- Price

n/a

e)

 

Date of the transaction

 

 

16 January 2023

 

f)

Place of transaction

Outside a trading venue

 

For more information:

 

Curtis Banks Group plc

via Instinctif Partners

David Barral - Executive Chairman

Dan Cowland - Chief Financial Officer

Peel Hunt LLP (Nominated Adviser & Broker)

+44 (0) 20 7418 8900

Andrew Buchanan

James Steel

Singer Capital Markets Limited (Joint Broker)

+44 (0) 20 7496 3000

Rick Thompson

James Moat

Instinctif Partners (investor relations adviser to Curtis Banks)

curtisbanks@instinctif.com

Tim Linacre

+44 (0) 20 7457 2020

Victoria Hayns

Joe Quinlan

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBGGDBXUBDGXR
Date   Source Headline
8th Jun 20204:36 pmRNSPrice Monitoring Extension
4th Jun 20201:24 pmRNSResult of AGM
2nd Jun 20204:40 pmRNSSecond Price Monitoring Extn
2nd Jun 20204:35 pmRNSPrice Monitoring Extension
29th May 20204:42 pmRNSSecond Price Monitoring Extn
29th May 20204:36 pmRNSPrice Monitoring Extension
1st May 20207:00 amRNSHolding(s) in Company
29th Apr 20205:02 pmRNSHolding(s) in Company
17th Apr 20204:40 pmRNSSecond Price Monitoring Extn
17th Apr 20204:35 pmRNSPrice Monitoring Extension
15th Apr 20204:40 pmRNSSecond Price Monitoring Extn
15th Apr 20204:35 pmRNSPrice Monitoring Extension
9th Apr 20207:00 amRNSPDMR share awards and Issue of options
18th Mar 20207:00 amRNSFinal Results
13th Mar 20204:40 pmRNSSecond Price Monitoring Extn
13th Mar 20204:35 pmRNSPrice Monitoring Extension
4th Feb 20207:00 amRNSNotice of Results
24th Sep 20193:18 pmRNSDirector/PDMR Shareholding
5th Sep 20197:00 amRNSInterim Results
7th Aug 201911:00 amRNSHolding(s) in Company
31st Jul 20197:00 amRNSNotice of Results
5th Jun 20197:00 amRNSAppointment of CFO
21st May 20195:09 pmRNSDirector/PDMR Shareholding
21st May 20194:45 pmRNSResult of AGM
30th Apr 20198:19 amRNSDirector/PDMR Shareholding
20th Mar 20197:00 amRNSFinal Results
31st Jan 20197:00 amRNSNotice of Results
22nd Jan 20198:30 amRNSNew Product Launch
18th Jan 20197:00 amRNSAppointment of Jane Ridgley to the Board
9th Jan 20197:00 amRNSDirectorate Change
11th Dec 20187:00 amRNSPurchase of Hargreave Hale SIPP book
9th Oct 20184:43 pmRNSDirector/PDMR Shareholding
8th Oct 201811:25 amRNSDirector/PDMR Shareholding
28th Sep 20189:08 amRNSHolding(s) in Company
6th Sep 20187:00 amRNSInterim Results
22nd Aug 20187:00 amRNSAppointment of Joint Broker
15th Jun 20189:15 amRNSNotice of Results
16th May 20183:30 pmRNSResult of AGM
30th Apr 201812:30 pmRNSTR-1: notification of major holdings
27th Apr 20185:15 pmRNSTR-1: notification of major holdings
26th Apr 20182:58 pmRNSResult of Placing
26th Apr 201811:20 amRNSProposed Placing
9th Apr 20189:00 amRNSJane Ridgley appointed Chief Operating Officer
27th Mar 20187:00 amRNSHolding(s) in Company
15th Mar 20187:00 amRNSFinal Results
16th Jan 20187:00 amRNSTrading Update
22nd Dec 20177:00 amRNSExercise of Options
18th Dec 20173:10 pmRNSUpdate on operating systems
16th Nov 20179:21 amRNSExercise of Options
10th Nov 201711:58 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.